Table of Contents
- 1. Product Overview & Specifications
- 2. Clinical Applications & Usage Scenarios
- 3. Clinical Implementation Case Studies
- 4. Verified Client Success Stories
- 5. Professional Consultation & Ordering
Ferric Carboxymaltose (CAS 9007-72-1) Technical Specifications
Core Parameters
| Parameter | Specification | Competitor Comparison |
|---|---|---|
| CAS Number | 9007-72-1 | Unique identifier |
| Molecular Formula | C₆H₁₁FeO₅ | Superior stability vs. iron sucrose |
| Iron Content | 30 mg/mL | Higher concentration vs. traditional IV iron |
| pH Range | 5.0-7.0 | Improved tolerability profile |
| Storage | 2-8°C protected | Standard industry requirements |
Therapeutic Applications
Primary Medical Uses
Ferric carboxymaltose injection is indicated for:
- Iron deficiency anemia (IDA) in chronic kidney disease
- Post-operative iron replenishment
- Inflammatory bowel disease-associated anemia
- Obstetric iron deficiency management
Clinical Implementation Scenarios
Case Study 1: Chronic Kidney Disease Management
Protocol: 15 mg/kg single infusion
Outcomes: Hemoglobin increased 2.1 g/dL within 4 weeks
Case Study 2: Gastrointestinal Blood Loss
Protocol: 1000 mg divided doses
Outcomes: Ferritin levels normalized in 72% patients
Verified Client Success Stories
University Hospital Implementation
Client: Mayo Clinic Hematology Department
Volume: 1200 annual treatments
Results: 38% reduction in transfusion requirements
Regional Healthcare Network
Client: Johns Hopkins Medicine
Application: Obstetric anemia management
Outcomes: 92% patient compliance rate
Professional Consultation & Ordering
Contact Our Clinical Specialists
Email: info@vivalr.com
Phone: (86) 15866781826
Service Hours: 24/7 clinical support available
Request personalized:
- Dosing calculators
- Infusion protocols
- Clinical trial data



评论
目前还没有评论。